Literature DB >> 21262525

Successful treatment of refractory acute GVHD complicated by severe intestinal transplant-associated thrombotic microangiopathy using recombinant thrombomodulin.

Yasuyuki Inoue, Shigeki Kosugi, Ikuo Miura, Yoshihiro Hatta, Jin Takeuchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21262525     DOI： 10.1016/j.thromres.2010.12.023

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  6 in total

Review 1.  Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies.

Authors:  J Khosla; A C Yeh; T R Spitzer; B R Dey
Journal:  Bone Marrow Transplant       Date:  2017-10-02       Impact factor: 5.483

Review 2.  Pathogenesis of graft-versus-host disease: innate immunity amplifying acute alloimmune responses.

Authors:  Yoshinobu Maeda
Journal:  Int J Hematol       Date:  2013-08-28       Impact factor: 2.490

3.  A donor thrombomodulin gene variation predicts graft-versus-host disease development and mortality after bone marrow transplantation.

Authors:  Haruka Nomoto; Akiyoshi Takami; J Luis Espinoza; Keitaro Matsuo; Shohei Mizuno; Makoto Onizuka; Koichi Kashiwase; Yasuo Morishima; Takahiro Fukuda; Yoshihisa Kodera; Noriko Doki; Koichi Miyamura; Takehiko Mori; Shinji Nakao; Shigeki Ohtake; Eriko Morishita
Journal:  Int J Hematol       Date:  2015-08-06       Impact factor: 2.490

Review 4.  Innate immune activation by tissue injury and cell death in the setting of hematopoietic stem cell transplantation.

Authors:  Todd V Brennan; Victoria R Rendell; Yiping Yang
Journal:  Front Immunol       Date:  2015-03-16       Impact factor: 7.561

Review 5.  Thrombomodulin in disseminated intravascular coagulation and other critical conditions-a multi-faceted anticoagulant protein with therapeutic potential.

Authors:  Takashi Ito; Jecko Thachil; Hidesaku Asakura; Jerrold H Levy; Toshiaki Iba
Journal:  Crit Care       Date:  2019-08-15       Impact factor: 9.097

6.  Early coagulation disorder after allogeneic stem cell transplantation is a strong prognostic factor for transplantation-related mortality, and intervention with recombinant human thrombomodulin improves the outcome: a single-center experience.

Authors:  Masayuki Nagasawa; Teppei Ohkawa; Akifumi Endo; Noriko Mitsuiki; Toshiaki Ono; Yuki Aoki; Takeshi Isoda; Daisuke Tomizawa; Masatoshi Takagi; Michiko Kajiwara; Tomohiro Morio; Shuki Mizutani
Journal:  Int J Hematol       Date:  2013-10-01       Impact factor: 2.319
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.